Market Place
Sourcing Support
All News #Library
Others
IceCure Appoints Shay Levav as COO to Drive Growth
10 Nov 2025 //
PR NEWSWIRE
Icecure Highlights Prosense® At TME Fall Summit Roundtable
13 Oct 2025 //
PR NEWSWIRE
IceCure Gets Israeli Approval for XSense™ Cryoablation System
15 Sep 2025 //
PR NEWSWIRE
IceCure`s ProSense® in THERMAC Trial: 95% Patient Satisfaction
08 Sep 2025 //
PR NEWSWIRE
IceCure`s ProSense Significantly Cut Abdominal Endometriosis Pain
04 Sep 2025 //
PR NEWSWIRE
Ice Cure Gets US Patent for Novel Cryogen Flow Control
09 Jun 2025 //
PR NEWSWIRE
IceCure`s ProSense Featured at SIO 2025 as FDA Decision Approaches
04 Feb 2025 //
PR NEWSWIRE
IceCure CEO Reports 42% Rise In ProSense® Sales In North America
13 Jan 2025 //
PR NEWSWIRE
IceCure’s ProSense® Cryoablation Effective in Kidney Tumor Treatment
05 Dec 2024 //
PR NEWSWIRE
Fda Panel For IceCure`s ProSense® Gets Many Public Comments
29 Oct 2024 //
PR NEWSWIRE
IceCure`s ICE3 5-Year Results Show 96.3% Recurrence-Free for Breast Cancer
24 Sep 2024 //
PR NEWSWIRE
European Study Supports IceCure`s ProSense For Breast Cancer Treatment
09 Jul 2024 //
PR NEWSWIRE
IceCure Receives Notice of Allowance in Japan for a Novel Cryogen Flow Control
12 Mar 2024 //
PR NEWSWIRE
IceCure Medical to Report Financial Results for the 9-Month Period Ended Sep
29 Nov 2022 //
PRNEWSWIRE
IceCure`s ProSense Cryoprobes and Introducers Receive Regulatory Approval
11 Oct 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.